1. Company debt last reported as $15 million in January 2012, and none of that debt repaid as far as anyone knows. Company hasn't filed financials suince 4th Qtr 2011 when they said they could not continue operations because they had no money.
2. Outcome of lawsuit: $2.5 million settlement agreed to by both sides, they convene in court on April 22nd, no money in escrow yet.
3. Absolutely no truth in that rumor.
That all said - -notice how many people are willing to buy this stock. In the penny biotech world, hype is worth more than the facts. Invest according to your risk tolerance.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.